Four companies to present at Innovation Theater; booth will demo the world’s first smart surgical glasses with AR and MR, hand diagnostics radiography imaging, knee replacement, limb salvage, and cartilage repair systems
LAS VEGAS, March 06, 2023--(BUSINESS WIRE)--AAOS – With the theme "Improving Lives, Together," Taiwan Excellence – the symbol of the best and most innovative Taiwanese products – will exhibit next-generation innovations that are bringing about positive change for a better life at the American Academy of Orthopaedic Surgeons (AAOS) 2023 Annual Meeting, March 7 – 11 in Las Vegas. The Pavilion will showcase products from four Taiwan Excellence award-winning companies: the world’s first smart surgical glasses with AR and MR from Taiwan Main Orthopaedics; hand diagnostics radiology imaging from NanoRay; a limb salvage system from United Orthopedic, and one-step cartilage repair technology from BioGend. These products are shaping new standards of care while improving people’s healthcare experiences and outcomes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230303005345/en/
Visit Taiwan Excellence Pavilion Booth #1855 at American Academy of Orthopaedic Surgeons 2023 Annual Meeting. (Graphic: Business Wire)
The Taiwan Excellence awards are awarded by the Taiwan Bureau of Foreign Trade (BOFT), Ministry of Economic Affairs, and Taiwan External Trade Development Council (TAITRA).
"Taiwan Excellence and our exhibiting companies are excited to engage with the orthopaedic surgeon community at AAOS to address growing demand for solutions that enhance the overall surgical experience," said Michael Liou, Director, Taipei Economic and Cultural Office in Los Angeles. "As aging populations and their healthcare needs continue to rise in the U.S. and around the world, innovations in orthopaedics will play a pivotal role in improving lives. Taiwan’s e-health and medical technology industry stand committed to supporting the medical and orthopaedics community to achieve excellence."
Company Presentations at Innovation Theater Booth #6643
Company executives from Taiwan Excellence’s four exhibiting companies will deliver presentations at the Innovation Theater at AAOS Booth #6643.
14:30 – 14:50: "Caduceus Surgical Glass for Spine Navigation," presented by Taiwan Main Orthopaedics.
11:00 – 11:20: "USTAR II Limb Salvage System," presented by United Orthopedic.
12:00 – 12:20: "RevoluX Hand Diagnostics Radiology Imaging System," presented by NanoRay.
13:30 – 13:50: "RevoCart One-Step Cartilage Repair Technology," presented by BioGend.
Visit Taiwan Excellence Pavilion Booth #1855
From March 8 to March 10, the four companies will showcase and demo their products at the Taiwan Excellence "Improving Lives, Together" pavilion located at Booth #1855:
1. BioGend – RevoCart® Cartilage Repair and Regeneration Technology
BioGend’s One-Step Autologous Cartilage Repair System, RevoCart®, is an innovative cartilage repair procedure and a milestone for knee cartilage surgery. As exercise gains more popularity and society continues to age, the number of people suffering from degenerative arthritis and sports-related joint injuries has been increasing. With a one-step minimally invasive procedure, this innovative technology has assisted many patients in successful autologous knee cartilage repair.
2. NanoRay – Revolux Hand Diagnostic Radiology Imaging System
The world’s first point-of-care low-dose benchtop hand radiography system, RevoluX, integrates NanoRay’s innovative Transmission X-Ray tube and an advanced flat-panel detector. The compact benchtop hand radiography system can be deployed in the general area without the need for radiation shielding, thus saving space and cost for healthcare facilities. RevoluX can provide fast, safe, and accurate analysis of the bone age growth curve of children. It can also be used in bone mineral density detection, rheumatoid joint disease, and additional early diagnosis research.
3. Taiwan Main Orthopaedics – Smart Surgical Glasses
Redefining the future of surgery, Taiwan Main Orthopaedics’ Caduceus smart glasses are the world’s first to combine mixed reality and high precision surgical navigation technologies, enabling surgeons to see through a patient's body and visualize a 3D model of the anatomy of the patient's organs. Caduceus is a surgical guidance system incorporated with core technologies to assist in positioning specific entry points and revealing necessary angles for fixing screws in spinal surgery. Surgeons can see the exact position of the needle insertion without taking their eyes off of the patient to look at any other instrumentation. For patients, it means smaller incisions during the procedure, resulting in quicker recovery times. Additionally, the Caduceus S augmented reality spine navigation system, which the smart glasses are a part of, recently received 510(k) clearance from the US Food and Drug Administration and is expected to be available in the US in the first quarter of 2023.
4. United Orthopedic – USTAR II Knee Hinge and Limb Salvage System
United Orthopedic’s United Segmental Total Articular Reconstruction System (USTAR II) is a limb salvage system designed for the extensive reconstruction of the hip and knee joint after revision or tumor removal surgery. USTAR II offers surgeons a simple solution for complex salvage cases through its innovative mechanisms and modular design. It offers a variety of choices in terms of proximal femoral components, segment lengths, and extension stems. It requires less resection, offers more preservation, and is safe and long lasting.
Interested attendees can request for meetings with exhibiting companies by clicking here. Media representatives can request for one-on-one media briefings by contacting mary@skc-pr.com.
Taiwan Excellence believes that only innovation can bring about change for a better life. A cross-disciplinary team of jurors search and hand select innovative brands in Taiwan that are breaking the mold in sustainability, design, research, and development. The Taiwan Excellence mark has become one of the world’s most coveted and recognizable symbols of quality and design, showcasing Taiwan’s outstanding product innovation around the globe. Please visit https://www.taiwanexcellence.org/en for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230303005345/en/
Mary Placido SKC, Inc. (415) 218-3627 mary@skc-pr.com
Adial Pharmaceuticals Inc (NASDAQ: ADIL) shares are trading higher after an update on its regulatory strategy for AD04, the company's lead compound for Alcohol Use Disorder (AUD). The company said additional analysis of ONWARD data identified specific genotypes that outperformed others. The data exhibited AD04 achieved a statistically significant reduction of heavy drinking days in a subgroup of patients - the "heavy drinkers." Adial believes there is a clear, cost-effective path toward FDA appr
An FDA advisory committee recommended approving Pfizer's (PFE) and GSK's respective RSV vaccines for older adults. Currently, there are no RSV vaccines anywhere in the world.
(Bloomberg) -- WW International Inc., previously known as WeightWatchers, surged by the most in more than seven years after striking a $132 million deal for a telehealth provider, a move that helps the company tap into the burgeoning market for a new class of weight-loss drugs.Most Read from BloombergMeta Plans Thousands More Layoffs as Soon as This WeekBiden Eyes Tax Hike on Income Over $400,000 to Fund MedicarePowell Sees Higher Peak for Interest Rates, Says Fed Prepared to Speed Up If NeededU
Walgreens faces backlash over misperception of its intent to sell abortion pill in some states.
Three drugs could lower the risk of heart attacks, strokes and other complications for patients who can’t take or benefit enough from statins.
The unprofitable biotech that pioneered novel cancer agents has caught the attention of the world’s largest drugmakers.
'Use of contaminated eye drops can result in the risk of eye infections that could result in blindness,' the makers of Purely Soothing eye drops said
'I’m afraid there will be violence': Mark Sawusch entered a mental spiral following acid trips with gurus Anthony Flores and Anna Moore, testimony shows
U.S. health officials are alerting consumers about two more recalls of eyedrops due to contamination risks that could lead to vision problems and serious injury. The announcements follow a recall last month of eyedrops made in India that were linked to an outbreak of drug-resistant infections. One person died and at least five others had permanent vision loss. The Food and Drug Administration posted separate recall notices for certain eyedrops distributed by Pharmedica and Apotex after the companies said they are voluntarily pulling several lots of their products from the market.
Results from Abbott's (ABT) PORTICO study support Navitor's recent FDA approval to treat patients with severe aortic stenosis who are at high or extreme risk for open-heart surgery.
President Joe Biden on Tuesday proposed new taxes on the rich to help fund Medicare, saying the plan would help to extend the insurance program's solvency by 25 years and provide a degree of middle-class stability to millions of older adults. In his plan, Biden is overtly declaring that the wealthy ought to shoulder a heavier tax burden. Biden wants to increase the Medicare tax rate from 3.8% to 5% on income exceeding $400,000 per year, including salaries and capital gains.
An L.A. County public hospital performed an unneeded surgery after its doctors received pay from the maker of the medical device they implanted, a whistleblower says.
Cytokinetics Incorporated (NASDAQ: CYTK) presented results from Cohort 4 of REDWOOD-HCM Phase 2 trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy (nHCM). At ten weeks, patients in Cohort 4 experienced significant improvements in NT-proBNP, with an average decrease of 66%. High-sensitivity troponin I level also improved significantly proportional to baseline at each study visit. Related: FDA Rejects Cytokinetics' Heart Failure Treatment Candidate. An improvement of ≥
WW International Inc, known as WeightWatchers, said on Monday it is acquiring subscription telehealth platform Sequence, moving the weight-loss program operator into the obesity drug prescription business. WeighWatchers said it expects its $132 million acquisition in cash and stock will complement its nutrition and behavior-change program for weight loss at a time when obesity drugs are seen as one of the biggest markets for drugmakers.
UnitedHealthcare, Centene, and Aetna have seen their revenue surge by billions as their membership soared by millions.
Walgreens’ stance on abortion pills is costing it business in one of America’s largest states.
Amarin Corporation plc (NASDAQ: AMRN) announced a new analysis from the Vascepa/Vazkepa (icosapent ethyl) cardiovascular outcomes REDUCE-IT study. The study exhibited the effectiveness of Vascepa/Vazkepa in patients with the recent acute coronary syndrome. The post-hoc analysis showed that icosapent ethyl (IPE) substantially and significantly reduced the risk of first and total ischemic events by 37% and 36%, respectively, in patients with the recent acute coronary syndrome (ACS) without increas
A recent study adds to mounting questions about the health effects of popular sugar substitutes found in everything from low-carb ice cream to baked goods.
Incyte (INCY) decides to scrap the LIMBER-304 study evaluating the efficacy and safety of parsaclisib plus Jakafi for myelofibrosis (MF) following an independent data monitoring committee recommendation.